Tạp chí Tim mạch học Việt Nam

Article detail

Article detail description

Home
CA LÂM SÀNG Issue: Số 122 - 2026 TIM MẠCH CAN THIỆP

Stent-Free Revascularization for Thrombotic Saphenous Vein Graft Occlusion Presenting as ST-segment Elevation Myocardial Infarction: A Case Report

Published: September 28, 2026
Views: 128

Abstract

Background: Percutaneous coronary intervention (PCI) for thrombotic saphenous vein graft (SVG) occlusion presenting as ST-segment elevation myocardial infarction (STEMI) carries a high risk of distal embolization, slow-flow, and no-reflow. Whether routine stent implantation is mandatory following successful thrombus reduction in selected SVG lesions remains uncertain. Case Presentation: A 70-year-old man with a history of coronary artery bypass grafting (CABG) and bioprosthetic aortic valve replacement presented with inferior STEMI complicated by cardiogenic shock due to acute thrombotic occlusion of an SVG to the right coronary artery (RCA). Repeated mechanical aspiration thrombectomy successfully restored TIMI 3 flow. Subsequent evaluation with intravascular ultrasound (IVUS) revealed a focal soft plaque with minimal residual thrombus. Following stepwise lesion preparation with a non-compliant balloon, residual stenosis was reduced to 30-40% without flow-limiting dissection. To eliminate the risk of stent-induced distal embolization and long-term graft failure, a stent-free revascularization strategy using a paclitaxel-coated balloon (DCB, 3.0 × 25 mm) was successfully executed. At the 5-month follow-up, the patient remained clinically stable without adverse cardiovascular events. Conclusions: Routine stenting may not be compulsory in selected thrombotic SVG lesions provided that adequate thrombus clearance, optimal lesion preparation, and intravascular imaging optimization are achieved. A stepwise stent-free approach incorporating aspiration thrombectomy, IVUS guidance, and selective DCB application provides a safe and effective individualized alternative in this high-risk scenario.

Keywords
Drug-coated balloon Intravascular ultrasound Percutaneous coronary intervention Saphenous vein graft ST-segment elevation myocardial infarction

References

1.
Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, pathophysiology, and prevention. Circulation. 1998;97(9):916-931.
2.
Brilakis ES, Edson R, Bhatt DL, et al. Percutaneous coronary intervention in native arteries versus saphenous vein grafts in patients with prior coronary artery bypass graft surgery. JACC Cardiovasc Interv. 2011;4(1):33-43.
3.
Brilakis ES. Manual of Percutaneous Coronary Interventions: A Step-by-Step Approach. 1st ed. Academic Press; 2020.
4.
Niccoli G, Scalone G, Lerman A, Crea F. Coronary no-reflow in the modern era: pathogenesis, pathophysiology, and treatment. EuroIntervention. 2016;12(2):189-199.
5.
Hong YJ, Jeong MH, Choi YH, et al. Impact of plaque components on no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction: a virtual histology-intravascular ultrasound study. EuroIntervention. 2011;7(2):220-226.
6.
Räber L, Mintz GS, Koskinas KC, et al. Clinical use of intracoronary imaging. Part 1: guidance and optimization of percutaneous coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. Eur Heart J. 2018;39(35):3281-3300.
7.
Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022;79(2):197-215.
8.
Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87-165.
9.
Baim DS, Wahr D, George B, et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aortocoronary bypass grafts (SAFER trial). Circulation. 2002;105(11):1285-1290.
10.
Jeger RV, Eccleshall S, Wan Ahmad WA, et al. Drug-coated balloons for coronary artery disease: third report of the International DCB Consensus Group. JACC Cardiovasc Interv. 2020;13(12):1391-1402.

Tác giả

Nguyễn Văn Hải: Bệnh viện Đa khoa Hồng Ngọc Phúc Trường Minh; Phạm Mạnh Hùng: Trường Đại học Y Hà Nội; Nguyễn Đình Công: Bệnh viện Đa khoa Hồng Ngọc Phúc Trường Minh; Cao Mạnh Hưng: Bệnh viện Đa khoa Hồng Ngọc Phúc Trường Minh;
Stent-Free Revascularization for Thrombotic Saphenous Vein Graft Occlusion Presenting as ST-segment Elevation Myocardial Infarction: A Case Report

Files

Article Views128
Document Views0
Downloads17
Section CA LÂM SÀNG
Category TIM MẠCH CAN THIỆP
Pages 152-159
Copyright Holder 2026 Tạp chí Tim mạch học Việt Nam